# NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO)

> **NIH NIH N01** · IIT RESEARCH INSTITUTE · 2023 · $1,425,732

## Abstract

This task order is for safety assessment studies of Drinabant to determine its toxicity and evaluate the implications

## Key facts

- **NIH application ID:** 10953972
- **Project number:** 271201700016I-P00006-759502000003-1
- **Recipient organization:** IIT RESEARCH INSTITUTE
- **Principal Investigator:** THOMAS HORN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $1,425,732
- **Award type:** —
- **Project period:** 2020-09-25 → 2024-04-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10953972

## Citation

> US National Institutes of Health, RePORTER application 10953972, NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO) (271201700016I-P00006-759502000003-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10953972. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*